Business Context and Reporting Period
This Form 8-K filing by Daxor Corporation (DXR) covers the reporting period of February 2, 2022. The filing announces a corporate event regarding the company's listing status.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing change event.
Material Changes
The primary material change reported is the commencement of trading for Daxor Corporation's common stock on the Nasdaq Capital Markets, effective February 2, 2022. The company previously traded on the NYSE American.
Outlook and Management Commentary
Management announced that the company will visit the Nasdaq Market Site on Friday, February 4, 2022, to ring the Opening Bell. No financial guidance, risk factors, or contingencies were disclosed in this specific filing.
Investor Verification Checklist
- Confirm the effective date of the trading venue change to Nasdaq Capital Markets.
- Verify the ticker symbol remains "DXR" on the new exchange.
- Review the attached press release (Exhibit 99.1) for additional context on the listing transition.